FDA Inspection 1014144 — Janssen Alanna L
The FDA completed an inspection of Janssen Alanna L on May 11, 2017 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- San Diego, CA (United States)
Additional Details
Clinical Investigator (CI)